Ischemic preconditioning increases the bioavailability of cardiac enkephalins

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 289, Issue 4 58-4, 2005, Pages

  Younès, Antoine ^b   Pepe, Salvatore ^c   Yoshishige, Darice ^d   Caffrey, James L ^d   Lakatta, Edward G ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Heart; Opioid peptide processing; Opioid peptides

Indexed keywords

ENKEPHALIN; ENKEPHALIN RECEPTOR; ENZYME INHIBITOR; LEUCINE ENKEPHALIN; METENKEPHALIN; METENKEPHALIN[6 ARGININE 7 PHENYLALANINE]; OPIATE PEPTIDE; PEPTIDASE; PEPTIDASE INHIBITOR; PROENKEPHALIN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; ENZYME INHIBITION; GEL PERMEATION CHROMATOGRAPHY; HEART DISEASE; HEART INFARCTION PREVENTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; INOTROPISM; ISOLATED HEART; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN LOCALIZATION; PROTEIN PROCESSING; RADIOIMMUNOASSAY; RAT;

ANIMALS; CORONARY CIRCULATION; ENKEPHALIN, LEUCINE; ENKEPHALIN, METHIONINE; ENKEPHALINS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; PROTEIN PRECURSORS; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 25444467972     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.01110.2004     Document Type: Article

References (38)

1. Barron BA, Gu H, Gaugl JF, and Caffrey JL. Screening for opioids in dog heart. J Mol Cell Cardiol 24: 67-77, 1992.
2. Bolling SF, Benedict MB, Tramontini NL, Kilgore KS, Harlow HH, Su TP, and Oeltegen PR. Hibernation triggers and myocardial protection. Circulation 98, Suppl: II220-II223, 1998.
3. Boluyt MO, Younès A, Caffrey JL, O'Neil L, Barron BA, Crow MT, and Lakatta EG. Age-associated increase in rat cardiac opioid production. Am J Physiol Heart Circ Physiol 265: H212-H218, 1993.
4. Caffrey JL. Enkephalin/catecholamine interactions in cardiac, skeletal, and intestinal muscle. J Am Osteopath Assoc 84, Suppl: 135-142, 1984.
5. 125I]Met-enkephalin. J Biochem Biophys Methods 6: 133-139, 1982.
6. Caffrey JL, Mateo Z, Napier LD, Gaugl JF, and Barron BA. Intrinsic cardiac enkephalins inhibit vagal bradycardia in the dog. Am J Physiol Heart Circ Physiol 268: H848-H855, 1995.
7. Caffrey JL, Wooldridge CB, and Gaugl JF. The interaction of endogenous opiates with autonomic circulatory control in the dog. Circ Shock 17: 233-242, 1985.
8. Chien GL, Mohtadi K, Wolf RA, and Van Winkle DM. Naloxone blockade of myocardial ischemia preconditioning does not require central nervous system participation. Basic Res Cardiol 94: 136-143, 1999.
9. Clement-Jones V, Lowry PJ, Rees LH, and Besser GM. Met-enkephalin circulates in human plasma. Nature 283: 295-297, 1980.
10. Colucci WS, Sawyer DB, Singh K, and Communal C. Adrenergic overload and apoptosis in heart failure: implications for therapy. J Card Fail 6, Suppl 1: 1-7, 2000.
11. Dumont M, Ouellette M, Brakier-Gingras L, and Lemaire S. Circadian regulation of the biosynthesis of cardiac Met-enkephalin and precursors in normotensive and spontaneously hypertensive rats. Life Sci 48: 1895-1902, 1991.
12. Farias M, Jackson K, Yoshishige, and Caffrey JL. Bimodal δ-opioid receptors regulate vagal bradycardia in canine sinoatrial node. Am J Physiol Heart Circ Physiol 285: H1332-H1339, 2003.
13. Gross ER, Hsu AK, and Gross GJ. Opioid-induced cardioprotection occurs via glycogen synthase kinase β inhibition during reperfusion in intact rat hearts. Circ Res 94: 960-966, 2004.
14. Gross GJ. Role of opioids in acute and delayed preconditioning. J Mol Cell Cardiol 35: 709-718, 2003.
15. Howells RD, Kilpatrick DL, Bailey LC, Noc M, and Udenfriend S. Proenkephalin mRNA in rat heart. Proc Natl Acad Sci USA 83: 1960-1963, 1986.
16. Jackson KE, Farias M, Stanfill AS, and Caffrey JL. Transient arterial occlusion raises enkephalin in the canine sinoatrial node and improves vagal bradycardia. Auton Neurosci Basic Cardiol 94: 84-92, 2001.
17. Juhaszova M, Zorov DB, Kim SH, Pepe S, Fu Q, Fishbein KW, Ziman B, Wang S, Ytrehus K, Antos CL, Olsen EN, and Sollott SJ. Glycogen synthase-3β mediates convergence of protection signaling to inhibit the mitochondrial permeability pore. J Clin Invest 113: 1535-1549, 2004.
18. 5-enkephalin protects against infarction in vivo. Am J Physiol Heart Circ Physiol 285: H2463-H2470, 2003.
19. Lovelace JL, Barron BA, and Caffrey JL. Differential degradation of methionine enkephalin (ME) and methionine enkephalin-Arg-Phe (MEAP) in canine myocardium (Abstract). FASEB J 12: A410, 1998.
20. Marks N, Benuck M, and Berg MJ. Metabolism of a heptapeptide opioid by rat brain and cardiac tissue. Life Sci 31: 1845-1848, 1982.
21. Meerson FZ, Dimitriev AD, Zaitas VI, Rozhitskaia II, and Kizim EA. Effects of stress, infarction and adaptation to brief exposure to stress on opioid peptide levels in the brain. Vopr Med Khim 31: 32-34, 1985.
22. Paradis P, Dumont M, Bélichard P, Rouleau JL, Lemaire S, and Brakier-Gingras L. Increased preproenkephalin A gene expression in the rat heart after the induction of myocardial infarction. Biochem Cell Biol 70: 593-598, 1992.
23. Pepe S, Xiao RP, Hohl C, Altschuld R, and Lakatta EG. "Cross talk" between opioid peptides and adrenergic receptor signaling in isolated rat heart. Circulation 95: 2122-2129, 1997.
24. Rao SM and Howells RD. Molecular cloning, sequence analysis and translation of proenkephalin mRNA from rat heart. Regul Pept 40: 397-408, 1992.
25. Rona G. Catecholamine cardiotoxicity. J Mol Cell Cardiol 17: 291-306, 1985.
26. Schultz JE, Rose E, Yao Z, and Gross GJ. Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol Heart Circ Physiol 268: H2157-H2161, 1995.
27. Springhorn JP and Claycomb WC. Proenkephalin mRNA expression in developing rat hearts and in cultured ventricular cardiac muscle cells. Biochem J 258: 73-78, 1989.
28. Springhorn JP and Claycomb WC. Translation of heart proenkephalin mRNA and secretion of enkephalin peptides from cultured cardiac myocytes. Am J Physiol Heart Circ Physiol 263: H1560-H1566, 1992.
29. Stanfill AA, Jackson KE, Farias M, Barlow M, Deo S, Johnson S, and Caffrey JL. Leucine-enkephalin interrupts sympathetically mediated tachycardia prejunctionally in canine sinoatrial node. Exp Biol Med 228: 898-906, 2003.
30. Ventura C and Maioli M. Opioid peptide gene expression primes cardiogenesis in embryonal pluripotent stem cells. Circ Res 87: 243-267, 2000.
31. Ventura C and Pintus G. Opioid peptide gene expression in the primary hereditary cardiomyopathy of the Syrian hamster. III. Autocrine stimulation of prodynorphin gene expression by dynorphin B. J Biol Chem 272: 6699-6705, 1997.
32. Ventura C, Guarnieri C, Vaona I, Campana G, Pintus G, and Spampinato S. Dynorphin gene expression and release in the myocardial cell. J Biol Chem 269: 5384-5386, 1994.
33. Ventura C, Pintus G, and Tadolini B. Opioid peptide gene expression in the primary hereditary cardiomyopathy of the Syrian hamster. II. Role of intracellular loading. J Biol Chem 272: 6693-6699, 1997.
34. 2+ release from an intracellular pool in myocytes and neurons. Circ Res 70: 66-81, 1992.
35. Williams IH, Chua BHL, Sahms RH, Siehl D, and Morgan HE. Effects of diabetes protein turnover in cardiac muscle. Am J Physiol Endocrinol Metab 239: E178-E185, 1980.
36. 2+-channel current. J Mol Cell Cardiol 25: 661-666, 1993.
37. Younès A, Pepe S, Barron BA, Spurgeon HA, Lakatta EG, and Caffrey JL. Cardiac synthesis, processing, and coronary release of enkephalin-related peptides. Am J Physiol Heart Circ Physiol 279: H1989-H1998, 2000.
38. Zimlichman R, Gefel D, Eliahou H, Matas Z, Rozen B, Gass S, Ela C, Eliman Y, Vogel Z, and Barg J. Expression of opioid receptors during heart ontogeny in normotensive and hypertensive rats. Circulation 93: 1020-1025, 1996.